TY - JOUR
T1 - Asthma Medication Ratio Phenotypes in Elderly Women
AU - Chanoine, Sébastien
AU - Pin, Isabelle
AU - Sanchez, Margaux
AU - Temam, Sofia
AU - Pison, Christophe
AU - Le Moual, Nicole
AU - Severi, Gianluca
AU - Boutron-Ruault, Marie Christine
AU - Fournier, Agnès
AU - Bousquet, Jean
AU - Bedouch, Pierrick
AU - Varraso, Raphaëlle
AU - Siroux, Valérie
N1 - Publisher Copyright:
© 2017 American Academy of Allergy, Asthma & Immunology
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Background: With population aging, further asthma research is needed in the elderly. Objective: We assessed the relevance of the controller-to-total asthma medication ratio and its fluctuations over time to identify participants with a subsequent risk of poor asthma-related outcomes among well-characterized elderly women. Methods: We studied 4,328 women with ever asthma (69.6 ± 6.1 years) from the Asthma-E3N study (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale), which combined drug claims data since 2004 with prospective individual characteristics. The levels of the yearly controller-to-total asthma medication ratio from 2004 to 2011 were included in latent class analysis to identify groups of women characterized by specific long-term fluctuations of the ratio. Multiple regression models estimated the subsequent risk of uncontrolled asthma, asthma attacks, asthma exacerbations, and poor asthma-related quality of life associated with the level and the fluctuations of the ratio. Results: A short-term (12 months) ratio below 0.5 was associated with a higher risk of subsequent uncontrolled asthma, asthma attacks, asthma exacerbations (odds ratio [95% confidence interval (CI)] = 2.13 [1.41; 3.23], 1.51 [1.01; 2.26], and 2.18 [1.37; 3.44], respectively), and a lower total asthma quality of life questionnaire score (β [95% CI] = −0.49 [−0.68; −0.29]). The analysis of the long-term fluctuations of the ratio identified 5 profiles (“Never regular treatment,” 53.2%; “Persistent high ratio,” 21.8%; “Increasing ratio,” 4.4%; “Initiating treatment,” 8.8%; “Treatment discontinuation,” 11.8%). The subsequent risk of poor asthma-related outcomes was significantly higher in profiles characterized by no or interrupted asthma maintenance therapy over time, compared with the “Persistent high ratio” group. Conclusions: The level and the long-term fluctuations of the controller-to-total asthma medication ratio predict poor asthma-related outcomes in elderly women.
AB - Background: With population aging, further asthma research is needed in the elderly. Objective: We assessed the relevance of the controller-to-total asthma medication ratio and its fluctuations over time to identify participants with a subsequent risk of poor asthma-related outcomes among well-characterized elderly women. Methods: We studied 4,328 women with ever asthma (69.6 ± 6.1 years) from the Asthma-E3N study (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale), which combined drug claims data since 2004 with prospective individual characteristics. The levels of the yearly controller-to-total asthma medication ratio from 2004 to 2011 were included in latent class analysis to identify groups of women characterized by specific long-term fluctuations of the ratio. Multiple regression models estimated the subsequent risk of uncontrolled asthma, asthma attacks, asthma exacerbations, and poor asthma-related quality of life associated with the level and the fluctuations of the ratio. Results: A short-term (12 months) ratio below 0.5 was associated with a higher risk of subsequent uncontrolled asthma, asthma attacks, asthma exacerbations (odds ratio [95% confidence interval (CI)] = 2.13 [1.41; 3.23], 1.51 [1.01; 2.26], and 2.18 [1.37; 3.44], respectively), and a lower total asthma quality of life questionnaire score (β [95% CI] = −0.49 [−0.68; −0.29]). The analysis of the long-term fluctuations of the ratio identified 5 profiles (“Never regular treatment,” 53.2%; “Persistent high ratio,” 21.8%; “Increasing ratio,” 4.4%; “Initiating treatment,” 8.8%; “Treatment discontinuation,” 11.8%). The subsequent risk of poor asthma-related outcomes was significantly higher in profiles characterized by no or interrupted asthma maintenance therapy over time, compared with the “Persistent high ratio” group. Conclusions: The level and the long-term fluctuations of the controller-to-total asthma medication ratio predict poor asthma-related outcomes in elderly women.
KW - Asthma
KW - Asthma medications
KW - Asthma phenotypes
KW - Drug claims data
KW - Elderly people
UR - http://www.scopus.com/inward/record.url?scp=85029698279&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2017.07.014
DO - 10.1016/j.jaip.2017.07.014
M3 - Article
C2 - 28958739
AN - SCOPUS:85029698279
SN - 2213-2198
VL - 6
SP - 897-906.e5
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 3
ER -